Chew EY, SanGiovanni JP, Ferris FL, et al. Lutein /zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol. 2013 Jul;131(7):843-50. View abstract.
Cho E, Seddon JM, Rosner B, et al. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 2004;122:883-92. View abstract.
Chung HY, Rasmussen HM, Johnson EJ. Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men. J Nutr 2004;134:1887-93. View abstract.
Cota F, Costa S, Giannantonio C, Purcaro V, Catenazzi P, Vento G. Lutein supplementation and retinopathy of prematurity: a meta-analysis. J Matern Fetal Neonatal Med 2020:1-6. Online ahead of print. View abstract.
Cui YH, Jing CX, Pan HW. Association of blood antioxidants and vitamins with risk of age-related cataract: a meta-analysis of observational studies. Am J Clin Nutr. 2013;98(3):778-86. View abstract.
Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 2000;71:147-64.. View abstract.
De Cosmi V, Cipriani S, Esposito G, et al. Vitamin and Carotenoid Intake and Outcomes of In Vitro Fertilization in Women Referring to an Italian Fertility Service: A Cross-Sectional Analysis of a Prospective Cohort Study. Antioxidants (Basel) 2023;12(2):286. View abstract.
Edwards CG, Walk AM, Thompson SV, et al. Dietary lutein plus zeaxanthin and choline intake is interactively associated with cognitive flexibility in middle-adulthood in adults with overweight and obesity. Nutr Neurosci 2021. View abstract.
Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 2023;9(9):CD000254. View abstract.
Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993;111:104-9.. View abstract.
Feng L, Nie K, Jiang H, Fan W. Effects of lutein supplementation in age-related macular degeneration. PLoS One 2019;14(12):e0227048. View abstract.
Fitzgerald KC, O'Reilly ÉJ, Fondell E, et al. Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies. Ann Neurol. 2013;73(2):236-45. View abstract.
Flood V, Smith W, Wang JJ, et al. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 2002;109:2272-8.. View abstract.
García-Layana A, Recalde S, Alamán AS, Robredo PF. Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial. Nutrients. 2013 Feb 15;5(2):543-51. View abstract.
Ge XX, Xing MY, Yu LF, et al. Carotenoid intake and esophageal cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2013;14(3):1911-8. View abstract.
Ghasemi F, Navab F, Rouhani MH, Amini P, Shokri-Mashhadi N. The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study. Prostaglandins Other Lipid Mediat 2022;164:106691. View abstract.
Glabska D, Guzek D, Zakrzewska P, Lech G. Intake of Lutein and Zeaxanthin as a Possible Factor Influencing Gastrointestinal Symptoms in Caucasian Individuals with Ulcerative Colitis in Remission Phase. J Clin Med 2019;8(1):77. View abstract.
Goodman GE, Schaffer S, Omenn GS, et al. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 2003;12:518-26. View abstract.
Gossage C, Deyhim M, Moser-Veillon PB, et al. Effect of beta-carotene supplementation and lactation on carotenoid metabolism and mitogenic T-lymphocyte proliferation. Am J Clin Nutr 2000;71:950-5. View abstract.
Gruber M, Chappell R, Millen A, et al. Correlates of serum lutein + zeaxanthin: findings from the Third National Health and Nutrition Examination Survey. J Nutr 2004;134:2387-94. View abstract.
Hajizadeh-Sharafabad F, Tarighat-Esfanjani A, Ghoreishi Z, Sarreshtedari M. Lutein supplementation combined with a low-calorie diet in middle-aged obese individuals: effects on anthropometric indices, body composition and metabolic parameters. Br J Nutr 2021;126(7):1028-1039. View abstract.
Hammond BR Jr, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997;38:1795-801.. View abstract.
Hammond BR Jr, Miller LS, Bello MO, Lindbergh CA, Mewborn C, Renzi-Hammond LM. Effects of Lutein/Zeaxanthin Supplementation on the Cognitive Function of Community Dwelling Older Adults: A Randomized, Double-Masked, Placebo-Controlled Trial. Front Aging Neurosci 2017;9:254. View abstract.
Hammond BR Jr, Wooten BR, Snodderly DM, et al. Density of the human crystalline lens is related to the macular pigment carotenoids, lutein and zeaxanthin. Optom Vis Sci 1997;74:499-504. View abstract.
Han W, Zhang W, Ren X. Not all carotenoids can reduce the risk of gastric cancer: a systematic review with meta-analysis. BMC Gastroenterol 2024;24(1):51. View abstract.
Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women: a prospective study. BMJ 1992;305:335-9. View abstract.
Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 2000;71:1555-62.. View abstract.
Juturu V, Bowman JP, Deshpande J. Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind, placebo-controlled clinical trial. Clin Cosmet Investig Dermatol 2016;9:325-332. View abstract.
Kai JY, Zhou M, Li DL, et al. Smoking, dietary factors and major age-related eye disorders: an umbrella review of systematic reviews and meta-analyses. Br J Ophthalmol 2022. View abstract.
Kang T, Liu Y, Chen X, et al. Dietary carotenoid intake and risk of developing preeclampsia: a hospital-based case-control study. BMC Pregnancy Childbirth 2022;22(1):427. View abstract.
Kawabata, F. and Tsuji, T. Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans. Biomed Res 2011;32(6):387-393. View abstract.
Knekt P, Ritz J, Pereira MA, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004;80:1508-20. View abstract.
Koh HH, Murray IJ, Nolan D, et al. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 2004;79:21-27. View abstract.
Koonsvitsky BP, Berry DA, et al. Olestra affects serum concentrations of alpha-tocopherol and carotenoids but not vitamin D or vitamin K status in free-living subjects. J Nutr 1997;127:1636S-45S. View abstract.
Korobelnik JF, Rougier MB, Delyfer MN, et al. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ?-3 on Macular Pigment: A Randomized Clinical Trial. JAMA Ophthalmol 2017;135(11):1259-1266. View abstract.
Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr 1995;62:604-10. View abstract.
Kotagiri SR, Morde A, Rai D, et al. Superior bioavailability of a novel lutein and zeaxanthin formulation in healthy human subjects. Ophthalmol Ther 2022;11(4):1463-1477. View abstract.
Lai JS, Veetil VO, Lanca C, et al. Maternal lutein and zeaxanthin concentrations in relation to offspring visual acuity at 3 years of age: The GUSTO Study. Nutrients 2020;12(2):274. View abstract.
Landrum JT, Bone RA, Joa H, et al. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 1997;65:57-62. View abstract.
Lee EH, Faulhaber D, Hanson KM, et al. Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression. J Invest Dermatol 2004;122:510-7. View abstract.
Leermakers ET, Darweesh SK, Baena CP, et al. The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis. Am J Clin Nutr 2016;103(2):481-94. View abstract.
Li J, Abdel-Aal EM. Dietary lutein and cognitive function in adults: A meta-analysis of randomized controlled trials. Molecules 2021;26(19):5794. View abstract.
Liang J, Wang Y, Chen M. The Association between Dietary Carotenoid Intake and Risk of Depression among Patients with Cardiometabolic Disease. Int Heart J 2023;64(2):223-229. View abstract.
Liu R, Wang T, Zhang B, et al. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014 Dec 16;56(1):252-8. Review. View abstract.
Liu XH, Yu RB, Liu R, et al. Association between lutein and zeaxanthin status and the risk of cataract: a meta-analysis. Nutrients. 2014 Jan 22;6(1):452-65. View abstract.
De, Marino S., Gala, F., Zollo, F., Vitalini, S., Fico, G., Visioli, F., and Iorizzi, M. Identification of minor secondary metabolites from the latex of Croton lechleri (Muell-Arg) and evaluation of their antioxidant activity. Molecules. 2008;13(6):1219-1229. View abstract.
Desmarchelier, C. J. and de Moraes Barros, S. B. Pharmacological activity of South American plants: effects on spontaneous in vivo lipid peroxidation. Phytother.Res. 2003;17(1):80-82. View abstract.
DiCesare, D., DuPont, H. L., Mathewson, J. J., Ashley, D., Martinez-Sandoval, F., Pennington, J. E., and Porter, S. B. A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico. Am.J.Gastroenterol. 2002;97(10):2585-2588. View abstract.
Froldi, G., Zagotto, G., Filippini, R., Montopoli, M., Dorigo, P., and Caparrotta, L. Activity of sap from Croton lechleri on rat vascular and gastric smooth muscles. Phytomedicine. 2009;16(8):768-775. View abstract.
Gonzales, G. F. and Valerio, L. G., Jr. Medicinal plants from Peru: a review of plants as potential agents against cancer. Anticancer Agents Med.Chem. 2006;6(5):429-444. View abstract.
Jones, K. Review of sangre de drago (Croton lechleri)--a South American tree sap in the treatment of diarrhea, inflammation, insect bites, viral infections, and wounds: traditional uses to clinical research. J.Altern.Complement Med. 2003;9(6):877-896. View abstract.
Lopes, M. I., Saffi, J., Echeverrigaray, S., Henriques, J. A., and Salvador, M. Mutagenic and antioxidant activities of Croton lechleri sap in biological systems. J.Ethnopharmacol. 2004;95(2-3):437-445. View abstract.
Milanowski, D. J., Winter, R. E., Elvin-Lewis, M. P., and Lewis, W. H. Geographic distribution of three alkaloid chemotypes of Croton lechleri. J.Nat.Prod. 2002;65(6):814-819. View abstract.
Miller, M. J., MacNaughton, W. K., Zhang, X. J., Thompson, J. H., Charbonnet, R. M., Bobrowski, P., Lao, J., Trentacosti, A. M., and Sandoval, M. Treatment of gastric ulcers and diarrhea with the Amazonian herbal medicine sangre de grado. Am.J.Physiol Gastrointest.Liver Physiol 2000;279(1):G192-G200. View abstract.
Miller, M. J., Vergnolle, N., McKnight, W., Musah, R. A., Davison, C. A., Trentacosti, A. M., Thompson, J. H., Sandoval, M., and Wallace, J. L. Inhibition of neurogenic inflammation by the Amazonian herbal medicine sangre de grado. J.Invest Dermatol. 2001;117(3):725-730. View abstract.
Pereira, U., Garcia-Le, Gal C., Le, Gal G., Boulais, N., Lebonvallet, N., Dorange, G., Lefeuvre, L., Gougerot, A., and Misery, L. Effects of sangre de drago in an in vitro model of cutaneous neurogenic inflammation. Exp.Dermatol. 2010;19(9):796-799. View abstract.
Porras-Reyes, B. H., Lewis, W. H., Roman, J., Simchowitz, L., and Mustoe, T. A. Enhancement of wound healing by the alkaloid taspine defining mechanism of action. Proc.Soc.Exp.Biol.Med. 1993;203(1):18-25. View abstract.
Risco, E., Ghia, F., Vila, R., Iglesias, J., Alvarez, E., and Canigueral, S. Immunomodulatory activity and chemical characterisation of sangre de drago (dragon's blood) from Croton lechleri. Planta Med. 2003;69(9):785-794. View abstract.
Rossi, D., Bruni, R., Bianchi, N., Chiarabelli, C., Gambari, R., Medici, A., Lista, A., and Paganetto, G. Evaluation of the mutagenic, antimutagenic and antiproliferative potential of Croton lechleri (Muell. Arg.) latex. Phytomedicine. 2003;10(2-3):139-144. View abstract.
Sandoval, M., Okuhama, N. N., Clark, M., Angeles, F. M., Lao, J., Bustamante, S., and Miller, M. J. Sangre de grado Croton palanostigma induces apoptosis in human gastrointestinal cancer cells. J.Ethnopharmacol. 2002;80(2-3):121-129. View abstract.
Tradtrantip, L., Namkung, W., and Verkman, A. S. Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels. Mol.Pharmacol. 2010;77(1):69-78. View abstract.
Tran, C. D., Butler, R. N., and Miller, M. J. The role of Amazonian herbal medicine Sangre de Grado in Helicobacter pylori infection and its association with metallothionein expression. Helicobacter. 2006;11(2):134-135. View abstract.
Williams, J. E. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern.Med.Rev. 2001;6(6):567-579. View abstract.
Alonso-Castro AJ, Ortiz-Sanchez E, Dominguez F, et al. Antitumor effect of Croton lechleri Mull. Arg. (Euphorbiaceae). J Ethnopharmacol 2012;140(2):438-42. View abstract.
Barnard DL, Huffman JH, Meyerson LR, Sidwell RW. Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303. Chemotherapy 1993;39:212-7. View abstract.
Barnard DL, Smee DF, Huffman JH, et al. Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid. Chemotherapy 1993;39:203-11. View abstract.
BioWorld Today. Shaman will sidestep FDA by selling product over internet website. Available at: https://www.bioworld.com. (Accessed 6 January 2000).
Chen ZP, Cai Y, Phillipson JD. Studies on the anti-tumour, anti-bacterial, and wound-healing properties of dragon's blood. Planta Med 1994;60:541-5. View abstract.
Coster H. One pharma entrepreneur's never ending quest. Forbes. Published 12/30/2010. Accessed 6/30/2017. Available at: https://www.forbes.com/forbes/2011/0117/entrepeneurs-pharma-prescriptions-lisa-conte-mission-impossible.html.
Crofelemer. FDA-Approved Drug Products. FDA Web site. Accessed 6/30/2017. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/.
Desmarchelier C, Witting Schaus F, Coussio J, Cicca G. Effects of Sangre de Drago from Croton lechleri Muell.-Arg. on the production of active oxygen radicals. J Ethnopharmacol 1997;58:103-8. View abstract.
Dicesare D, Dupont HL, Mathewson JJ, et al. A double-blind randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Mexico and Jamaica. Infectious Diseases Society of America Annual Meeting, 1998 (abstract).
Frampton JE. Crofelemer: a review of its use in the management of non-infectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy. Drugs 2013;73(10):1121-9. View abstract.
Fulyzaq [package insert]. Salix Pharmaceuticals, Inc.; Raleigh, NC: December 2012. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf.
Gabriel SE, Davenport SE, Steagall RJ, et al. A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion. Am J Physiol 1999;276:G58-G63. View abstract.
Gilbert BE, Wyde PR, Wilson SZ, Meyerson LR. SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats. Antiviral Res 1993;21:37-45. View abstract.
Holodniy M, Koch J, Mistal M, et al. A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS. Am J Gastroenterol 1999;94:3267-73. View abstract.
MacArthur RD, Hawkins T, Brown SJ, et al. Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study. HIV Clin Trials 2013;14(6):261-73. View abstract.
Mangel AW, Chaturvedi P. Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients. Digestion 2008;78(4):180-6. View abstract.
Miller MJ, Vergnolle N, Wallace JL, et al. Sangre de grado is a potent and unique inhibitor of neurogenic inflammation and promotes healing in experimental necrotizing enterocolitis. Pediatric Academic Soc and Acad Pediatrics Joint Mtg, May 12-6 2000:Abstract 979.
Nee J, Salley K, Ludwig AG, et al. Randomized clinical trial: crofelemer treatment in women with diarrhea-predominant irritable bowel syndrome. Clin Transl Gastroenterol. 2019;10(12):e00110. View abstract.
Orozco-Topete R, Sierra-Madero J, Cano-Dominguez C, et al. Safety and efficacy of Virend for topical treatment of genital and anal herpes simplex lesions in patients with AIDS. Antiviral Res 1997;35:91-103. View abstract.
Perdue GP, Blomster RN, Blake DA, Farnsworth NR. South American plants II: taspine isolation and anti-inflammatory activity. J Pharm Sci 1979;68:124-6. View abstract.
Pieters L, de Bruyne T, Claeys M, et al. Isolation of a dihydrobenzofuran lignan from South American dragon's blood (Croton spp.) as an inhibitor of cell proliferation. J Nat Prod 1993;56:899-906. View abstract.
Raintree Nutrition. Sangre de Grado website: www.rain-tree.com/sangre.htm (Accessed 31 January 2000).
Safrin S, McKinley G, McKeough M, et al. Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303. Antiviral Res 1994;25:185-92. View abstract.
Sidwell RW, Huffman JH, Moscon BJ, Warren RP. Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid. Chemotherapy 1994;40:42-50. View abstract.
Styczynski J, Wysocki M. Alternative medicine remedies might stimulate viability of leukemic cells. Pediatr Blood Cancer 2006;46:94-8. View abstract.
USDA, ARS, National Genetic Resources Program. Germplasm Resources Information Network - (GRIN). Taxon: Croton lechleri mull. Arg website: www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl?croton+lechleri (Accessed 31 January 2000).
Vaisberg AJ, Milla M, Planas MC, et al. Taspine is the cicatrizant principle in Sangre de Grado extracted from Croton lechleri. Planta Med 1989;55:140-3. View abstract.
Wyde PR, Ambrose MW, Meyerson LR, Gilbert BE. The antiviral activity of SP-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats. Antiviral Res 1993;20:145-54. View abstract.
You Might Also Like
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.